Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1991
12/16/1991WO1991019719A1 Substituted naphthoxazines useful as dopaminergics
12/16/1991CA2083146A1 Substituted naphthoxazines useful as dopaminergics
12/16/1991CA2044808A1 Anti-diabetic agents and veterinary anti-diabetic agents
12/16/1991CA2044509A1 Amorphous gemfibrozil
12/15/1991WO1991019702A1 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
12/15/1991WO1991019692A2 Calcium citrate malate composition
12/15/1991WO1991019484A1 Injectable pharmaceutical composition
12/15/1991CA2084898A1 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
12/14/1991CA2044405A1 N-oxyimidic acid derivatives
12/12/1991WO1991018982A1 Type ii interleukin-1 receptors
12/12/1991WO1991018923A1 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
12/12/1991WO1991018915A1 NOVEL α-GLUCOSIDASE INHIBITORS
12/12/1991WO1991018903A1 Pyrrolopyridazine compounds
12/12/1991WO1991018619A1 Apo ai polypeptides, antibodies, and immunoassays
12/12/1991WO1991018594A1 The pharmacological use of certain cystine derivatives
12/12/1991WO1991018591A1 Inhibition of viral infection
12/12/1991CA2042526A1 Method for preventing a second heart attack employing an hmg coa reductase inhibitor
12/11/1991EP0460846A1 Type II interleukin-1 receptors
12/11/1991EP0460690A2 Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
12/11/1991EP0460488A1 Sulfur-containing heterocyclic compounds
12/11/1991EP0460080A1 Orally administerable calcium supplement for cattle.
12/10/1991US5071990 Preparation of intermediates and the synthesis of n-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidines
12/10/1991US5071975 Esterification of sucrose with fatty acid alkyl esters, alkaline catalyst
12/10/1991US5071874 L-carnitine magnesium citrate
12/10/1991US5071841 Sulfur-containing heterocyclic compounds useful for the treatment of osteoporosis, and their production
12/10/1991US5071838 Treatment of shock by cyclodextrins and their derivatives
12/10/1991US5071669 Sucrose octaesters with myristic acid groups, triglycerides with saturated fatty acids, including behenic acid
12/10/1991US5071655 Pharmaceutical combination for treatment of bone-wasting diseases
12/07/1991WO1991018617A1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
12/06/1991WO1991019704A2 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
12/06/1991WO1991019476A1 Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof
12/06/1991CA2084399A1 Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof
12/06/1991CA2084195A1 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
12/04/1991EP0459632A1 Composition and method for controlling cholesterol
12/04/1991EP0459449A1 Furano[2,3-F]isoindoles as aldose reductase inhibitors
12/04/1991EP0459432A1 Treatment of diseases with paf-acether antagonists and procedure for determining their efficacy
12/04/1991CN1056690A Pyrrolopyridazine compounds
12/03/1991US5070103 Naphthalene derivatives and composition and methods of use, and aldehyde intermediates
12/03/1991US5070096 Quinolinoxy phenylsulphonamides
12/03/1991US5069913 Vanadium-peroxide compositions as insulin mimickers
12/01/1991CA2043468A1 Sulfur-containing heterocyclic compounds
11/1991
11/28/1991WO1991018027A2 Compounds
11/28/1991WO1991017985A1 Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds
11/28/1991CA2083512A1 Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds
11/27/1991EP0458640A2 Use of ergoline derivatives for the treatment of diseases associated with bone demineralization
11/27/1991EP0458551A1 Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
11/27/1991EP0458549A1 N-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
11/27/1991EP0457919A1 Functional food
11/27/1991CN1056495A Substituted 5-(2-(2-(2-aryl-2 hydroxyethyl) amino) propyl)-1,3-benzodioxoles
11/26/1991US5068337 1,4-dihydropyridines and their ability to inhibit blood platelet aggregation, inhibit thromboxane synthetase and phospholipase
11/26/1991US5068333 Aldose reductase inhibitors
11/26/1991US5068332 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
11/26/1991US5068251 Lipoxygenase inhibiting compounds
11/26/1991US5068239 Tetrazoleacetic acid derivatives and use for aldose reductase inhibitory activity
11/26/1991US5068221 Gonadotropin Releasing Hormone, oligopeptides for gastrointestinal disorders
11/26/1991CA2042960A1 Method of inhibiting demineralization of bone
11/21/1991EP0457539A1 Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
11/21/1991EP0457514A1 Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
11/21/1991EP0456928A1 Pasty dialyzing composition for perfusing artificial kidney systems and process for preparing same
11/21/1991EP0456835A1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof
11/20/1991CN1014787B Phenoxyacetic acid derivative and processes for preparing same
11/19/1991CA1292240C Triglyceride composition
11/19/1991CA1292233C 5-(w-phenethylamino-alkyl)-4,5,6,7-tetrahydro-thieno- (3,2-c)-pyridine derivatives
11/19/1991CA1292145C Nutritional fat suitable for enteral and parenteral products
11/18/1991CA2041846A1 Therapeutic agents
11/17/1991WO1991018593A1 Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders
11/17/1991CA2080818A1 Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyerproliferative disorders
11/14/1991WO1991017504A1 Fault tolerant computer system
11/14/1991WO1991017151A1 New pharmacologically active catechol derivatives
11/14/1991WO1991016919A1 Synthetic peptides for arterial imaging
11/14/1991WO1991016899A1 Composition for solid pharmaceutical preparations containing vitamin d3 derivative and process for preparation thereof
11/14/1991WO1991011453A3 5-oxygenated-2,4,6-triaminopyrimidines
11/14/1991CA2081569A1 Composition for solid pharmaceutical preparations containing vitamin d3 derivative and process for preparation thereof
11/14/1991CA2080493A1 Synthetic peptides for arterial imaging
11/13/1991EP0456214A1 Fluorinated derivatives of mevinic acids
11/13/1991EP0456185A2 Renin inhibitors
11/13/1991EP0455682A1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides.
11/13/1991EP0236385B1 A superoxide dismutase
11/13/1991CN1056104A Process for preparing nojirimycin derivatives
11/13/1991CN1056101A 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use
11/13/1991CN1056056A Composition and method for controlling cholesterol
11/12/1991US5064856 Novel hmg-coa synthase inhibitors
11/12/1991US5064841 Antilipemic agents; atherosclerosis
11/12/1991US5064839 1,4-dihydropyridines with a 2-amino group or with an ether group in a side chain
11/12/1991US5064829 Composition of a b vitamin and mannitol and a method for production
11/12/1991CA2041825A1 Renin inhibitors
11/12/1991CA2040530A1 Fluorinated derivatives of mevinic acids
11/12/1991CA1292000C Solid forms of 2-ethoxy-4-[n-(1-(2-piperidino- phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid
11/12/1991CA1291990C Antiatherosclerotic tetrasubstituted ureas and thioureas
11/07/1991DE4014252A1 (-)-1-(4'-Amino-3'-cyanophenyl)-2-iso-propyl-amino-ethanol - for treating fatty degeneration, obstructive lung disorders, allergic bronchial asthma, spastic bronchitis and premature labour
11/06/1991EP0455432A1 Alpha-glycosyl naringin, and its preparation and uses
11/06/1991EP0455155A1 Separation of cimaterol enantiomers
11/06/1991EP0455042A1 Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
11/06/1991EP0455006A2 Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
11/05/1991US5063247 Anticholesterol enzyme inhibitors
11/05/1991US5063240 Novel compounds
11/05/1991US5063234 Method of inhibiting demineralization of bone
11/05/1991US5063210 Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
11/05/1991CA2041712A1 Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
11/03/1991CA2040996A1 Composition and method for controlling cholesterol
1 ... 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 ... 1298